My research interest is in skeletal biology, focusing on development, growth and degenerative processes of the skeleton in health and disease. The emphasis is on genes regulating the linear growth of long bones, the formation of a synovial joint, and the intervertebral disc of the spine. The approach is to identify novel disease genes and to model the disease in mice to define the precise molecular and developmental changes.
In addressing the molecular basis for metaphyseal chondrodysplasia type Schmid (MCDS), a human condition with an abnormal growth plate causing dwarfism, we showed that the consequence is from activating ER-stress signal in hypertrophic chondrocytes that induces a “reprogramming” event, and the cells become “rejuvenated” (22). We provided detailed analysis of the cellular outcome (11) and potential therapeutic options (4, 8). Understanding this “reprogramming” progress not only has implications in the control of chondrocyte differentiation, but also regenerative strategies for degenerative cartilage and bone diseases.
A related goal is to understand the signals controlling joint formation, with an emphasis in the formation of digit joints. In address the molecular consequence of brachydactyly type A1 (BDA1), we provided novel insights into how mutations in the IHH gene alter the signaling capacity and range of hedgehog proteins, as these mutations impair IHH interaction with partner molecules (20). Through this, we identified a novel population of progenitor cells within the developing joint expressing Lgr5, and lineage tracing of these cells showed the progression to a Col22a1 expression juvenile articular cartilage chondrocyte (3). We propose that these are the “true” progenitor cells best suited for the repair of damaged cartilage in knee or other synovial joints.
I coordinate a Human Genetic Research Programme aiming to identify genetic risk factors for intervertebral disc (IVD) degeneration, a major cause of back pain. The aim is to understand the etiology of disc degeneration and a mean derive new strategies in the prevention and treatment of the disease. Through a candidate gene approach, we showed that Asporin (21) and CHST3 (14) as a new genetic risk factors for intervertebral disc degeneration We also use mouse as a model to understand the molecular and cellular basis of these risk factors. We also leverage on mouse genetics to identify protective factors in mice with good tissue healing potentials such as the LG/J or MRL strains (5), as well as the generation of progenitor cells as a treatment for intervertebral disc degeneration (1).
As my area of my expertise is in the extracellular matrix proteins; a new direction in my lab is to use the regenerative Planarian as a model organism to study the extracellular matrix niche of stem cell maintenance. Planarians have extraordinary potentials to regenerate missing body parts that could provide vital clues for the developing of novel regenerative strategies.